These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1677073)

  • 1. Immunoglobulin therapy.
    Lancet; 1991 Jul; 338(8760):157-8. PubMed ID: 1677073
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-A, non-B hepatitis from intravenous immunoglobulin.
    Lane RS
    Lancet; 1983 Oct; 2(8356):974-5. PubMed ID: 6138539
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulin.
    Lancet; 1979 Dec; 2(8153):1168-9. PubMed ID: 91896
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulin in pregnancy.
    Smith CI; Hammarström L
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):39S-40S. PubMed ID: 4022515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular and intravenous administration of immunoglobulin to patients with hypogammaglobulinemia.
    Hanson LA; Björkander J; Wadsworth C
    Birth Defects Orig Artic Ser; 1983; 19(3):205-7. PubMed ID: 6652239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous gammaglobulin for immunodeficiency: report from The European Group for Immunodeficiencies (EGID).
    Clin Exp Immunol; 1986 Sep; 65(3):683-90. PubMed ID: 2430746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Substitution with immunoglobulins in primary antibody deficiency syndrome].
    Morell A; Barandun S
    Beitr Infusionther Klin Ernahr; 1982; 9():16-24. PubMed ID: 6756383
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency.
    Björkander J; Cunningham-Rundles C; Lundin P; Olsson R; Söderström R; Hanson LA
    Am J Med; 1988 Jan; 84(1):107-11. PubMed ID: 3122562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of intravenous immunoglobulin treatment.
    Atrah HI; Crawford RJ; Dow BC; Mitchell R
    J Clin Pathol; 1985 Oct; 38(10):1192-3. PubMed ID: 3932489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of skin necrosis with subcutaneous immunoglobulin therapy.
    Datta R; Kuruvilla M; Gill M; de la Morena MT
    Ann Allergy Asthma Immunol; 2014 Aug; 113(2):232-3. PubMed ID: 24996991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Congenital IgG-agammaglobulinemia. Clinical-therapeutical, biochemical and genetic views on a case].
    Ohlenschläger G; Berger I
    Med Klin; 1974 Mar; 69(10):417-22. PubMed ID: 4133843
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Toxicity of intravenous Corynebacterium parvum.
    Ossorio RC; Fahey JL; Wilson W; Plotkin D; Brossman S; Skinner D
    Lancet; 1975 Nov; 2(7944):1090-1. PubMed ID: 53574
    [No Abstract]   [Full Text] [Related]  

  • 13. [Human immunoglobulins in therapy. Rational bases and clinical applications].
    Dammacco F; Perosa F; Campobasso N
    Ric Clin Lab; 1983; 13 Suppl 1():1-21. PubMed ID: 6344179
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of immunoglobulin preparations for intravenous use.
    Barandun S; Isliker H
    Vox Sang; 1986; 51(2):157-60. PubMed ID: 3535252
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoglobulin transmits hepatitis C. True or false?
    Piazza M
    Hepatology; 1999 Jan; 29(1):299-300. PubMed ID: 9935341
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion-related hepatitis.
    Chapel H; Bird G
    QJM; 1995 Mar; 88(3):221. PubMed ID: 7767673
    [No Abstract]   [Full Text] [Related]  

  • 17. Human immunoglobulin for clinical use.
    Lane RS; Vallet L; Kavanagh ML
    Lancet; 1983 Feb; 1(8320):357-8. PubMed ID: 6130360
    [No Abstract]   [Full Text] [Related]  

  • 18. Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin.
    Welch MJ; Stiehm ER
    J Clin Immunol; 1983 Jul; 3(3):285-6. PubMed ID: 6885970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century.
    Moore ML; Quinn JM
    Ann Allergy Asthma Immunol; 2008 Aug; 101(2):114-21; quiz 122-3, 178. PubMed ID: 18727465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Advisory Committee on Immunization (NACI). Statement on safety of immune globulin preparations.
    Can Dis Wkly Rep; 1988 Jun; 14(24):103. PubMed ID: 3149550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.